Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05217810 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Final enrollment: 670 participants (planned 600) · Primary and study completion dates: Dec 23, 2026 to Dec 24, 2026 · Interventions: Atectura inhalation capsule (150/160ug) (Other), Atectura inhalation capsule (150/320ug) (Other), Atectura inhalation capsule (150/80ug)… to Atectura inhalation capsule (150/160ug) (Other), Atectura inhalation capsule (150/320ug) (Other), Atectura inhalation capsule (150/80ug)… · 3 more Show 6 more changesShow less
    • Final enrollment: 670 participants (planned 600)
    • Primary and study completion dates: Dec 23, 2026 to Dec 24, 2026
    • Interventions: Atectura inhalation capsule (150/160ug) (Other), Atectura inhalation capsule (150/320ug) (Other), Atectura inhalation capsule (150/80ug)… to Atectura inhalation capsule (150/160ug) (Other), Atectura inhalation capsule (150/320ug) (Other), Atectura inhalation capsule (150/80ug)…
    • Secondary endpoints: details revised at 5 of 6 entries
    • Site details revised at 18 of 18 sites
    • Eligibility criteria expanded, about 5 words
  2. Study sites: 1 to 18v11
  3. 2 versions Re-verified since Feb 7, 2024, no change to tracked fieldsv9-v10
  4. Start date: Jun 16, 2022 to May 9, 2022 Site details revisedv8 Show 1 more changeShow less
    • Site details revised
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jun 30, 2022 to Jun 16, 2022v6 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 30, 2022 to Jun 16, 2022
  2. Re-verified, no change to tracked fieldsv5
  3. Start date: May 2, 2022 to Jun 30, 2022v4
  4. Enrollment target: 660 to 600v3
  5. Start date: Jan 31, 2022 to May 2, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Novartis
555 trials monitored
See 31 trials at risk
Asthma
927 trials monitored
See 32 trials at risk
This surveillance was designed as a prospective, open-label, multicenter, single-arm, non-interventional, observational study to evaluate the safety and effectiveness of Atectura inhalation capsule for up to 24 weeks under routine clinical practice.
Trial Details
NCT Number NCT05217810
Lead Sponsor Novartis Pharmaceuticals
Conditions Asthma
Enrollment 670 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov